Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Adenocarcinoma × talazoparib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 15 Triple Negative Breast Neoplasms 9 Neoplasms 7 Prostatic Neoplasms 6 Ovarian Neoplasms 4 Neoplasm Metastasis 4 Leukemia, Myeloid, Acute 4 Fallopian Tube Neoplasms 4 Endometrial Neoplasms 4 Small Cell Lung Carcinoma 2 Colorectal Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Wilms Tumor 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Triple Negative Metastatic Breast Cancer 1 Thrombocythemia, Essential 1 Sarcoma, Ewing 1 Sarcoma 1 Rhabdomyosarcoma 1 Rhabdoid Tumor 1 Recurrence 1 Prostate Cancer Metastatic 1 Primary Myelofibrosis 1 Premenopausal HR+/HER2- Metastatic Breast Cancer 1 Polycythemia Vera 1 Pathologic Complete Response 1 Osteosarcoma 1 Neuroendocrine Tumors 1 Neuroectodermal Tumors, Primitive, Peripheral 1

Interventions

Oxaliplatin 31 Fluorouracil 23 Gemcitabine 19 Leucovorin 18 Docetaxel 18 pembrolizumab 17 Capecitabine 15 Radiotherapy 13 Irinotecan 13 Bevacizumab 11 Cisplatin 10 Nivolumab 8 130-nm albumin-bound paclitaxel 8 Cyclophosphamide 7 Trastuzumab 6 Radiosurgery 6 Paclitaxel 6 Albumin-Bound Paclitaxel 6 S 1 (combination) 5 Metformin 5 Erlotinib Hydrochloride 5 Carboplatin 5 Blood Specimen Collection 5 Taxes 4 Sunitinib 4 Sorafenib 4 Pemetrexed 4 Esophagectomy 4 Chemoradiotherapy 4 Cetuximab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06844383 2025-10-29

TALENT

Prostate Cancer Clinical Trials Consortium

Phase 2 Recruiting

Adenocarcinoma, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡